SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

4 Nov 2016 07:00

RNS Number : 3068O
Tullett Prebon PLC
04 November 2016
 

4 November 2016

Tullett Prebon plc

 

 

 

Q3 Trading Update

 

Tullett Prebon plc is today issuing a trading update in relation to the period from 1 July to 30 September 2016.

 

Revenue in the third quarter to 30 September 2016 of £216m was 15% higher than the £188m revenue for the same period last year, and 4% higher at constant exchange rates. In the nine months to September, revenue of £647m was 7% higher than the £603m revenue for the same period last year, and 2% higher at constant exchange rates.

Reported revenue grew strongly in the third quarter due to the impact of foreign exchange, with around 60% of the group's revenue denominated in US dollars. During the period we have benefited from volatility associated with political uncertainty and speculation around the potential for further interest rate increases.

 

In the first nine months we continued to benefit from our acquisitions in Energy and Commodities as the division increased revenue 10% year on year at constant exchange rates. Information Sales and RMS have continued to see strong growth in the current quarter, with an increase of 28% in revenue (at constant exchange rates). In the first nine months their revenue increased 20% (at constant exchange rates).

 

In November 2015, we announced the proposed acquisition of the global hybrid voice broking and information businesses of ICAP plc. We are continuing to work with ICAP towards securing the outstanding regulatory approvals for completion of the transaction, including from the FCA.

 

John Phizackerley, Tullett Prebon CEO, said: "This has been a satisfactory quarter, with a number of products and regions showing gains. While some trading conditions remain challenging, our strategy of diversification and cost control is proving effective."

 

 

Notes to Editors

 

Tullett Prebon (www.tullettprebon.com) is one of the world's leading interdealer brokers and operates as an intermediary in wholesale financial markets facilitating the trading activities of its clients in seven major product groups: Energy & Commodities, Rates, Volatility, Treasury, Non-Banking, Credit and Equities.

With offices in 24 countries, Tullett Prebon operates voice, hybrid, electronic, volume matching, algorithmic matching and risk mitigation platforms, to accommodate the needs of its clients, and to satisfy the regulatory driven evolution of the marketplace. In addition to its brokerage services, Tullett Prebon offers a variety of market information services through its IDB Market Data division, Tullett Prebon Information.

Tullett Prebon has its principal offices in London, New Jersey, Hong Kong, Singapore and Tokyo, with other offices, joint ventures and affiliates in Bangkok, Connecticut Dubai, Frankfurt, Geneva, Houston, Jakarta, Johannesburg, Luxembourg, Madrid, Manama, Manila, Mexico City, Mumbai, New York, Paris, São Paulo, Seoul, Shanghai, Sydney, Toronto, Vienna and Warsaw.

Enquiries:

Tullett Prebon plc

 

Analysts/investors:

Sam Dobbyn, +44 (0)20 7200 7147

sdobbyn@tullettprebon.com

 

Media:

Rebecca Shelley, +44 (0)20 7200 7750

rshelley@tulletprebon.com

 

Brunswick Group

 

Kim Fletcher

Eilis Murphy

+44 (0)20 7404 5959

tullettprebon@brunswickgroup.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKXLFBQFFBFBE
Date   Source Headline
17th May 20235:05 pmRNSResult of AGM
17th May 20237:00 amRNSTrading Statement
13th Apr 202312:30 pmRNSHolding(s) in Company
5th Apr 20233:00 pmRNSDirector/PDMR Shareholding
4th Apr 202311:00 amRNSNotice of AGM and Committee Membership Changes
3rd Apr 20235:05 pmRNSDirector/PDMR Shareholding
29th Mar 20234:00 pmRNSHolding(s) in Company
23rd Mar 202311:00 amRNSDirector/PDMR Shareholding
22nd Mar 202311:00 amRNS2022 Annual Report and Accounts
14th Mar 20237:00 amRNSTP ICAP Group PLC - Final Results
8th Feb 20234:19 pmRNSChanges to Senior Independent Director
13th Dec 202210:00 amRNSHolding(s) in Company
6th Dec 20225:15 pmRNSHolding(s) in Company
1st Nov 20227:00 amRNSTrading Statement
27th Oct 20225:30 pmRNSHolding(s) in Company
25th Oct 20225:50 pmRNSHolding(s) in Company
13th Sep 20225:32 pmRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
28th Jul 20225:22 pmRNSResult of External Audit Tender
30th Jun 20225:44 pmRNSHolding(s) in Company
27th May 20223:30 pmRNSDirector/PDMR Shareholding
11th May 20226:01 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
4th May 20224:27 pmRNSGrant of Options and Director/PDMR Shareholding
22nd Apr 20224:49 pmRNSHolding(s) in Company
11th Apr 20224:17 pmRNSHolding(s) in Company
5th Apr 202211:02 amRNSAnnual Financial Report
4th Apr 20224:03 pmRNSDirector/PDMR Shareholding
31st Mar 20226:03 pmRNSDirector/PDMR Shareholding
29th Mar 20225:44 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSFinal Results
11th Jan 202211:35 amRNSHolding(s) in Company
22nd Dec 20215:00 pmRNSAppointment of new director
13th Dec 20213:24 pmRNSDirector/PDMR Shareholding
12th Nov 20212:04 pmRNSShareholder meeting update and PDMR transactions
12th Nov 20211:57 pmRNSTotal Voting Rights
2nd Nov 20217:00 amRNSTrading update - three months ended 30/09/2021
11th Oct 20214:00 pmRNSDirector/PDMR Shareholding
11th Oct 20213:01 pmRNSParameta Solutions Investor Seminar
7th Oct 202110:40 amRNSDirector/PDMR Shareholding
20th Sep 20214:58 pmRNSDirector/PDMR Shareholding
8th Sep 20215:08 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20217:00 amRNSTrading Statement
22nd Jun 20214:36 pmRNSDirector/PDMR Shareholding
18th May 202111:20 amRNSDirector/PDMR Shareholding
12th May 20215:49 pmRNSResult of AGM
12th May 20217:00 amRNSTrading Statement
23rd Apr 20215:10 pmRNSGrant of Options and Director/PDMR Shareholding
6th Apr 20214:32 pmRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.